Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 25 | $3,079,680 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Sep 2024 20:50 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 13 Sep 2024 | Sale | 60,046 | 4.221 | 253,454 | D |
16 Sep 2024 20:50 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 12 Sep 2024 | Sale | 28,611 | 4.4727 | 127,968 | D |
16 Sep 2024 20:49 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 13 Sep 2024 | Sale | 10,937 | 4.221 | 46,165 | D |
16 Sep 2024 20:49 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 12 Sep 2024 | Sale | 5,212 | 4.4727 | 23,312 | D |
16 Sep 2024 20:48 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 13 Sep 2024 | Sale | 20,946 | 4.221 | 88,413 | D |
16 Sep 2024 20:48 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 12 Sep 2024 | Sale | 9,980 | 4.4727 | 44,638 | D |
16 Sep 2024 20:47 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 13 Sep 2024 | Sale | 19,158 | 4.221 | 80,866 | D |
16 Sep 2024 20:47 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 12 Sep 2024 | Sale | 9,128 | 4.4727 | 40,827 | D |
16 Sep 2024 20:46 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 13 Sep 2024 | Sale | 84,008 | 4.221 | 354,598 | D |
16 Sep 2024 20:46 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 13 Sep 2024 | Sale | 16,304 | 4.221 | 68,819 | D |
16 Sep 2024 20:46 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 12 Sep 2024 | Sale | 40,029 | 4.4727 | 179,038 | D |
16 Sep 2024 20:46 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 12 Sep 2024 | Sale | 7,769 | 4.4727 | 34,748 | D |
23 Aug 2024 18:13 | MREO | Mereo BioPharma Group plc | PAKIANATHAN DEEPIKA | Director | 22 Aug 2024 | Sale | 105,244 | 4.4298 | 466,210 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 26 Jun 2024 | Sale | 32,187 | 3.3932 | 109,217 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SERMON CHARLES | General Counsel | 25 Jun 2024 | Sale | 14,202 | 3.6939 | 52,461 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 26 Jun 2024 | Sale | 16,808 | 3.3932 | 57,033 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | LEWICKI JOHN A. | Chief Scientific Officer | 25 Jun 2024 | Sale | 7,416 | 3.6939 | 27,394 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 26 Jun 2024 | Sale | 29,439 | 3.3932 | 99,892 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | FOX CHRISTINE ANN | Chief Financial Officer | 25 Jun 2024 | Sale | 12,990 | 3.6939 | 47,984 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 26 Jun 2024 | Sale | 92,273 | 3.3932 | 313,101 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | SCOTS-KNIGHT DENISE | Chief Executive Officer | 25 Jun 2024 | Sale | 40,712 | 3.6939 | 150,386 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 26 Jun 2024 | Sale | 22,968 | 3.3932 | 77,935 | D |
27 Jun 2024 16:15 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 25 Jun 2024 | Sale | 10,134 | 3.6939 | 37,434 | D |
23 May 2024 21:54 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 22 May 2024 | Sale | 50,082 | 2.94 | 147,241 | D |
23 May 2024 21:54 | MREO | Mereo BioPharma Group plc | HUGHES-WILSON ALEXANDRA | See Remarks | 22 May 2024 | Sale | 50,350 | 2.99 | 150,546 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)